Definitive Groove, de onderneming achter Newsmonkey, heeft discreet een kapitaalverhoging van 200.000 euro uitgevoerd. In één beweging werd de naam van de onderneming ook gewijzigd.
Definitive Groove, de onderneming achter Newsmonkey, heeft discreet een kapitaalverhoging van 200.000 euro uitgevoerd. In één beweging werd de naam van de onderneming ook gewijzigd.
Het kabinet spreekt alsnog grote waardering uit voor leden en nabestaanden van de Stay Behind-organisatie, een ultrageheime verzetsgroep die tijdens de Koude Oorlog klaarstond om het gewapend verzet te gaan vormen. Het is voor het eerst dat de Nederlandse regering publiekelijk de organisatie prijst.
EudraVigilance - Moderna covid MRNA vaccine up to 13/2/21Thierry Debels
This document summarizes data on 1,497 individual cases reported for the COVID-19 mRNA Vaccine Moderna (CX-024414) in EudraVigilance. The majority of cases were reported in individuals aged 18-64 (71.1%) and 65-85 (14.1%), with females representing 74.5% of cases. Most cases originated from countries in the European Economic Area (62.4%), with the remaining 37.6% from non-EEA countries. The data is broken down by age group, sex, geographic origin, and over time.
Mogelijke bijwerkingen Pfizer-vaccin Europa tot 13/2/21Thierry Debels
Over the last 12 months, EudraVigilance has identified over 30,000 individual cases of reactions to TOZINAMERAN, with the number of reported cases from EEA countries trending upwards and exceeding those from non-EEA countries. The dashboard displays the total number of cases over time and broken down by country and reaction type to monitor safety signals. Users are directed to key considerations on interpreting the results on the ADR reports website.
List of meetings Bill & Melinda Gates Foundation has held with Commissioners,...Thierry Debels
List of meetings Bill & Melinda Gates Foundation has held with Commissioners, Members of their Cabinet or
Director-Generals since 01/12/2014 under its current ID number in the Transparency Register:
371567915480-41.
This document contains summaries of data from EudraVigilance on individual cases reported over time and by different attributes. It includes charts and tables showing the number of cases by age group, sex, and geographic origin within and outside the European Economic Area, with females ages 18-64 making up the largest percentages.
BioNTech SE is a biopharmaceutical company that develops novel immunotherapies for cancer and other serious diseases. It has 2 employees who spend 25% of their time engaging with the European Commission and European Investment Bank regarding mRNA drugs and vaccines. BioNTech's annual costs for EU-related activities are between €50,000-99,999 and it received over €50 million in grants from Horizon 2020, FP7, and the EIB between 2019-2020.
